Exelixis greenshoe exercised, raising follow-on stock sale to $96.6 million

By Lisa Kerner

Charlotte, N.C., Oct. 10 - Exelixis, Inc. said its underwriters exercised the 1.5 million share over-allotment option in full, raising the size of its stock sale to 11.5 million shares or $96.6 million.

The company originally priced 10 million shares at $8.40 each after the market close on Oct. 4.

Goldman, Sachs & Co. was bookrunner, and Cowen and Co. LLC was joint lead manager. Banc of America Securities LLC and Piper Jaffray & Co. acted as co-managers.

Exelixis is a biotechnology company based in South San Francisco, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.